Mesentech drugs used in development of new anabolic-biomaterials at the University of Toronto
Researchers at the University of Toronto are incorporating Mesentech's bone-specific drugs to create a new anabolic-bone-biomaterial for surgical indications with the hope crating a stronger more natural bone much faster than currently available techniques.